Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Mattsson

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Clinical Science (London, England : 1979)|October 29, 2002
Serum levels of androgens and migraine in postmenopausal womenPeter Mattsson
Headache|July 17, 2003
Hormonal factors in migraine: a population-based study of women aged 40 to 74 yearsPeter Mattsson
Lakartidningen|April 26, 2012
[Four kilograms of prejudice celebrated as science. Herman Lundborg and the population in the garden of Sweden]Peter Mattsson
European Journal of Public Health|June 21, 2002
The name of a drug used for the treatment of migrainePeter Mattsson
Acta Radiologica (Stockholm, Sweden : 1987)|February 23, 2010
Metabolite concentrations in supraventricular white matter from teenage to early old age: A short echo time 1H magnetic resonance spectroscopy (MRS) studyRaili Raininko, Peter Mattsson
Lakartidningen|April 3, 2008
[Low prescription rates of generic lamotrigine and gabapentine]Peter Mattsson, Thomas Lindqvist
Seizure|March 16, 2010
Attitudes towards epilepsy surgery: A nationwide survey among Swedish neurologistsEva Kumlien, Peter Mattsson
Lakartidningen|August 7, 2023
Peter Mattsson, Jonas Furberg, Johan Zelano
Clinical Science (London, England : 1979)|December 26, 2001
Prostaglandin F(2alpha) metabolite and F(2)-isoprostane excretion rates in migraineJohanna Helmersson, Peter Mattsson, Samar Basu
Journal of Neurology, Neurosurgery, and Psychiatry|September 21, 2010
Physical fitness, but not muscle strength, is a risk factor for death in amyotrophic lateral sclerosis at an early agePeter Mattsson, Ingrid Lönnstedt, Ingela Nygren, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Clinical Science (London, England : 1979)|October 29, 2002
Serum levels of androgens and migraine in postmenopausal womenPeter Mattsson
Headache|July 17, 2003
Hormonal factors in migraine: a population-based study of women aged 40 to 74 yearsPeter Mattsson
Lakartidningen|April 26, 2012
[Four kilograms of prejudice celebrated as science. Herman Lundborg and the population in the garden of Sweden]Peter Mattsson
European Journal of Public Health|June 21, 2002
The name of a drug used for the treatment of migrainePeter Mattsson
Acta Radiologica (Stockholm, Sweden : 1987)|February 23, 2010
Metabolite concentrations in supraventricular white matter from teenage to early old age: A short echo time 1H magnetic resonance spectroscopy (MRS) studyRaili Raininko, Peter Mattsson
Lakartidningen|April 3, 2008
[Low prescription rates of generic lamotrigine and gabapentine]Peter Mattsson, Thomas Lindqvist
Seizure|March 16, 2010
Attitudes towards epilepsy surgery: A nationwide survey among Swedish neurologistsEva Kumlien, Peter Mattsson
Lakartidningen|August 7, 2023
Peter Mattsson, Jonas Furberg, Johan Zelano
Clinical Science (London, England : 1979)|December 26, 2001
Prostaglandin F(2alpha) metabolite and F(2)-isoprostane excretion rates in migraineJohanna Helmersson, Peter Mattsson, Samar Basu
Journal of Neurology, Neurosurgery, and Psychiatry|September 21, 2010
Physical fitness, but not muscle strength, is a risk factor for death in amyotrophic lateral sclerosis at an early agePeter Mattsson, Ingrid Lönnstedt, Ingela Nygren, et al.
Pageof 2